Predictors of bony morbidity in children with acute lymphoblastic leukemia

Pediatric Blood and Cancer

Volumn 59, Issue 1, 2012, Pages 77-82

  Rayar, Meera S ^a   Nayiager, Trishana ^b   Webber, Colin E ^c   Barr, Ronald D ^a,b   Athale, Uma H ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Acute lymphoblastic leukemia; Children; Fracture; Osteopenia; Osteoporosis

Indexed keywords

DEXAMETHASONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; BONE DENSITY; CHILD; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; LEUKEMIA REMISSION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OSTEOPENIA; OSTEOPOROSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DENSITY; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MODELS, BIOLOGICAL; OSTEOPOROSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SPINAL FRACTURES;

EID: 84861217598     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24040     Document Type: Article

References (37)

1. Pui C-H, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009; 360: 2730-2741.
2. Brenner H, Kaatsch P, Burkhadt-Hammer T, et al. Longterm survival of children with leukemia achieved by the end of the second millennium. Cancer 2001; 92: 1977-1983.
3. Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 1995; 126: 557-564.
4. Athanassiadou F, Trigiannidis A, Rousso I. Evaluation of bone metabolism in children with acute lymphoblastic leukemia after induction chemotherapy treatment. Pediatr Hematol Oncol 2005; 22: 285-289.
5. Wasilewski-Masker K, Kaste SC, Hudson MM, et al. Bone mineral density deficits in survivors of childhood cancer: Long term follow up guidance and review of literature. Pediatrics 2008; 121: e705-e712.
6. Sala A, Barr RD. Osteopenia and cancer in children and adolescents: The fragility of success. Cancer 2007; 109: 1420-1431.
7. Mandel K, Atkinson S, Barr RD, et al. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 2004; 22: 1215-1221.
8. Kaste SC, Chesney RW, Hudson MM, et al. Bone mineral status during and after therapy of childhood cancer: An increasing population with multiple risk factors for impaired bone health. J Bone Miner Res 1999; 14: 2010-2014.
9. Cromer B, Harel Z. Adolescents: At increased risk for osteoporosis? Clin Pediatr (Phila) 2000; 39: 565-574.
10. Vassilopoulou-Sellin R, Brosnan P, Delpassand A, et al. Osteopenia in young adult survivors of childhood cancer. Med Pediatr Oncol 1999; 32: 272-278.
11. Atkinson SA, Fraher L, Gundberg CM, et al. Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J Pediatr 1989; 114: 793-800.
12. Hochberg Z. Mechanisms of steroid impairment of growth. Horm Res 2002; 58: 33-38.
13. Canalis E, Mazziott G, Giustina A. Glucocorticoid-induced osteoporosis: Pathophysiology and therapy. Osteopor Int 2007; 18: 1319-1328.
14. Kaste SC. Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer 2008; 50: 469-473.
15. Ward L, Tricco A, Phuong PN, et al. Bisphosphonate therapy for children and adolescents with secondary osteoporosis (Review). Cochrane Database Syst Rev. 2007; 4: CD005324.
16. Wiernikowski JT, Barr RD, Webber C, et al. Alendronate for steroid -induced osteopenia in children with acute lymphoblastic leukemia or non-Hodgkin's lymphoma: Results of a pilot study. J Oncol Pharm Pract 2005; 11: 51-56.
17. Lethaby C, Wiernikowski J, Sala A, et al. Alendronate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence. A report of preliminary experience. J Pediatr Hematol Oncol 2007; 29: 613-616.
18. Diaz PR, Neira LC, Fischer SG, et al. Effect of 1, 25(OH)2-vitamin D on bone mass in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2008; 30: 15-19.
19. Silverman LB, Stevenson KE, O'Brien JE, et al. Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia 2010; 24: 320-334.
20. Sala A, Webber CE, Morrison J, et al. Whole body bone mineral content, lean body mass and fat mass measured by dual energy X-ray absorptiometry in a population of normal Canadian children and adolescents. Can Assoc Radiol J 2007; 58: 46-52.
21. Webber CE, Beaumont LF, Morrison J, et al. Age-predicted values for lumbar spine, proximal femur, and whole body bone mineral density: Results from a population of normal children aged 3-18 years. Can Assoc Radiol J 2007; 58: 37-45.
22. Bishop N, Braillon P, Burnham J, et al. Dual-energy X-ray absorptiometry assessment in children and adolescents with diseases that may affect the skeleton: The 2007 ICSD pediatric official positions. J Clin Densitom 2008; 11: 29-42.
23. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome of children with acute lymphoblastic leukemia: Results of Dana-Faber consortium protocol 91-01. Blood 2001; 97: 1211-1218.
24. Van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, et al. Altered bone mineral density and body composition and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr 2002; 141: 204-210.
25. Van der Sluis IM, van den Heuvel-Eibrink MM. Osteoporosis in children with cancer. Pediatr Blood Cancer 2008; 50: 474-478.
26. Strauss AJ, Su JT, Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol 2001; 19: 3066-3072.
27. Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 2001; 15: 728-734.
28. Davies JH, Evans BA, Gregory JW. Bone mass acquisition in healthy children. Arch Dis Child 2005; 90: 373-387.
29. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-795.
30. Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1998; 20: 234-240.
31. Kaste SC, Tong X, Hendrick JM, et al. QCT versus DXA in 320 survivors of childhood cancer; association of BMD with fracture history. Pediatr Blood Cancer 2006; 47: 936-943.
32. Jones TS, Kaste SC, Liu W, et al. CRHR1 polymorphisms predict bone density in survivors of acute lymphoblastic leukemia. J Clin Oncol 2008; 66: 3031-3037.
33. Gilsanz V, Gibbens DT, Roe TF, et al. Vertebral bone density in children: Effect of puberty. Radiology 1988; 166: 847-850.
34. Garnett SP, Hogler W, Blades B, et al. Relation between hormones and body composition, including bone, in prepubertal children. Am J Clin Nutr 2004; 80: 966-972.
35. Nelson DA, Simpson PM, Johnson CC, et al. The accumulation of whole body skeletal mass in third- and fourth-grade children: Effect of age, gender, ethnicity and body composition. Bone 1997; 20: 73-78.
36. Ma DQ, Jones D. Clinical risk factors but not bone density are associated with prevalent risk factors in prepubertal children. J Paediatr Child Health 2002; 38: 497-500.
37. Halton JM, Hay J, Atkinson SA, et al. Physical activity and bone mineralisation in children during treatment for acute lymphoblastic leukemia. Proc Am Soc Pediatr Hematol Oncol 1993; 2: 22 (abstr).